# Community West Bancshares: financial statements, quarterly

CWBC · Nasdaq · CIK 1127371 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cwbc.md) · [Financials](/companies/cwbc/financials.md) · [Filings](/companies/cwbc/filings.md) · [Insiders](/companies/cwbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cwbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [5.9](/filings/0001127371-23-000152.md) | [5.7 d](/filings/0001628280-24-041802.md) | [6.6](/filings/0001628280-24-023222.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.1](/filings/0001628280-24-045661.md) | [1.8 d](/filings/0001628280-26-016895.md) | [1.1](/filings/0001628280-25-024009.md) | [(1.6)](/filings/0001628280-25-039049.md) | [0.8](/filings/0001628280-25-050353.md) | [3.0 d](/filings/0001628280-26-016895.md) | [3.1](/filings/0001628280-26-032457.md) | [2.9](/filings/0001628280-26-055293.md) | [4.2](/filings/0001628280-25-050353.md) | [4.2 d](/filings/0001628280-26-016895.md) | [4.2](/filings/0001628280-26-032457.md) | [1.5](/filings/0001628280-26-055293.md) |
| Net income | $m | [6.4](/filings/0001628280-24-045661.md) | [5.9 d](/filings/0001628280-26-016895.md) | [3.7](/filings/0001628280-25-024009.md) | [(6.3)](/filings/0001628280-25-039049.md) | [3.4](/filings/0001628280-25-050353.md) | [6.9 d](/filings/0001628280-26-016895.md) | [8.3](/filings/0001628280-26-032457.md) | [7.8](/filings/0001628280-26-055293.md) | [10.9](/filings/0001628280-25-050353.md) | [11.2 d](/filings/0001628280-26-016895.md) | [11.5](/filings/0001628280-26-032457.md) | [2.7](/filings/0001628280-26-055293.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001628280-24-045661.md) | not reported | [0.31](/filings/0001628280-25-024009.md) | [(0.33)](/filings/0001628280-25-039049.md) | [0.18](/filings/0001628280-25-050353.md) | not reported | [0.44](/filings/0001628280-26-032457.md) | [0.41](/filings/0001628280-26-055293.md) | [0.57](/filings/0001628280-25-050353.md) | not reported | [0.60](/filings/0001628280-26-032457.md) | [0.10](/filings/0001628280-26-055293.md) |
| Basic EPS | $ per share | [0.54](/filings/0001628280-24-045661.md) | not reported | [0.31](/filings/0001628280-25-024009.md) | [(0.33)](/filings/0001628280-25-039049.md) | [0.18](/filings/0001628280-25-050353.md) | not reported | [0.44](/filings/0001628280-26-032457.md) | [0.41](/filings/0001628280-26-055293.md) | [0.57](/filings/0001628280-25-050353.md) | not reported | [0.60](/filings/0001628280-26-032457.md) | [0.10](/filings/0001628280-26-055293.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [74.6](/filings/0001127371-23-000152.md) | [53.7](/filings/0001628280-25-013157.md) | [61.0](/filings/0001628280-24-023222.md) | [110](/filings/0001628280-24-036559.md) | [149](/filings/0001628280-24-045661.md) | [120](/filings/0001628280-26-016895.md) | [148](/filings/0001628280-25-024009.md) | [134](/filings/0001628280-25-039049.md) | [122](/filings/0001628280-25-050353.md) | [119](/filings/0001628280-26-055293.md) | [130](/filings/0001628280-26-032457.md) | [207](/filings/0001628280-26-055293.md) |
| Total assets | $m | [2,435](/filings/0001127371-23-000152.md) | [2,433](/filings/0001628280-25-013157.md) | [2,416](/filings/0001628280-24-023222.md) | [3,485](/filings/0001628280-24-036559.md) | [3,531](/filings/0001628280-24-045661.md) | [3,522](/filings/0001628280-26-016895.md) | [3,553](/filings/0001628280-25-024009.md) | [3,577](/filings/0001628280-25-039049.md) | [3,612](/filings/0001628280-25-050353.md) | [3,690](/filings/0001628280-26-055293.md) | [3,703](/filings/0001628280-26-032457.md) | [5,034](/filings/0001628280-26-055293.md) |
| Total liabilities | $m | [2,254](/filings/0001127371-23-000152.md) | [2,226](/filings/0001628280-25-013157.md) | [2,204](/filings/0001628280-24-023222.md) | [3,134](/filings/0001628280-24-036559.md) | [3,168](/filings/0001628280-24-045661.md) | [3,159](/filings/0001628280-26-016895.md) | [3,181](/filings/0001628280-25-024009.md) | [3,197](/filings/0001628280-25-039049.md) | [3,215](/filings/0001628280-25-050353.md) | [3,281](/filings/0001628280-26-055293.md) | [3,284](/filings/0001628280-26-032457.md) | [4,426](/filings/0001628280-26-055293.md) |
| Long-term debt | $m | not reported | [69.7](/filings/0001628280-25-013157.md) | not reported | not reported | not reported | [69.9](/filings/0001628280-26-016895.md) | not reported | not reported | not reported | [69.5](/filings/0001628280-26-016895.md) | not reported | not reported |
| Short-term borrowings | $m | [0.0](/filings/0001127371-23-000152.md) | [80.0](/filings/0001628280-24-023222.md) | [67.0](/filings/0001628280-24-023222.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [182](/filings/0001628280-24-045661.md) | [207](/filings/0001628280-26-016895.md) | [212](/filings/0001628280-25-039049.md) | [350](/filings/0001628280-25-050353.md) | [364](/filings/0001628280-25-050353.md) | [363](/filings/0001628280-26-055293.md) | [372](/filings/0001628280-26-055293.md) | [380](/filings/0001628280-26-055293.md) | [398](/filings/0001628280-25-050353.md) | [410](/filings/0001628280-26-055293.md) | [419](/filings/0001628280-26-055293.md) | [608](/filings/0001628280-26-055293.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.0 d](/filings/0001628280-24-045661.md) | [4.1 d](/filings/0001628280-26-016895.md) | [4.0](/filings/0001628280-25-024009.md) | [5.2 d](/filings/0001628280-25-039049.md) | [7.8 d](/filings/0001628280-25-050353.md) | [5.2 d](/filings/0001628280-26-016895.md) | [11.1](/filings/0001628280-26-032457.md) | [11.5 d](/filings/0001628280-26-055293.md) | [13.2 d](/filings/0001628280-25-050353.md) | [10.3 d](/filings/0001628280-26-016895.md) | [10.9](/filings/0001628280-26-032457.md) | [19.6 d](/filings/0001628280-26-055293.md) |
| Capital expenditure | $m | [1.3 d](/filings/0001628280-24-045661.md) | [5.2 d](/filings/0001628280-26-016895.md) | [0.4](/filings/0001628280-25-024009.md) | [0.4 d](/filings/0001628280-25-039049.md) | [2.5 d](/filings/0001628280-25-050353.md) | [1.6 d](/filings/0001628280-26-016895.md) | [0.3](/filings/0001628280-26-032457.md) | [1.0 d](/filings/0001628280-26-055293.md) | [0.4 d](/filings/0001628280-25-050353.md) | [0.8 d](/filings/0001628280-26-016895.md) | [2.7](/filings/0001628280-26-032457.md) | [2.1 d](/filings/0001628280-26-055293.md) |
| Dividends paid | $m | [1.4 d](/filings/0001628280-24-045661.md) | [1.4 d](/filings/0001628280-26-016895.md) | [1.4](/filings/0001628280-25-024009.md) | [2.3 d](/filings/0001628280-25-039049.md) | [2.3 d](/filings/0001628280-25-050353.md) | [2.3 d](/filings/0001628280-26-016895.md) | [2.3](/filings/0001628280-26-032457.md) | [2.3 d](/filings/0001628280-26-055293.md) | [2.3 d](/filings/0001628280-25-050353.md) | [2.3 d](/filings/0001628280-26-016895.md) | [2.3](/filings/0001628280-26-032457.md) | [3.3 d](/filings/0001628280-26-055293.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-24-045661.md) | [0.0 d](/filings/0001628280-26-016895.md) | [0.0](/filings/0001628280-25-024009.md) | [0.0 d](/filings/0001628280-25-039049.md) | [0.0 d](/filings/0001628280-25-050353.md) | [0.0 d](/filings/0001628280-26-016895.md) | [0.1](/filings/0001628280-26-032457.md) | [0.1 d](/filings/0001628280-26-055293.md) | [0.0 d](/filings/0001628280-25-050353.md) | [0.0 d](/filings/0001628280-26-016895.md) | [0.1](/filings/0001628280-26-032457.md) | [0.2 d](/filings/0001628280-26-055293.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.7](/filings/0001127371-23-000152.md) | [11.7](/filings/0001628280-24-023222.md) | [11.7](/filings/0001628280-24-036559.md) | [11.8](/filings/0001628280-24-045661.md) | [11.8](/filings/0001628280-25-024009.md) | [18.9](/filings/0001628280-25-039049.md) | [19.0](/filings/0001628280-25-050353.md) | [19.0](/filings/0001628280-26-032457.md) | [19.0](/filings/0001628280-26-055293.md) | [19.1](/filings/0001628280-25-050353.md) | [19.1](/filings/0001628280-26-032457.md) | [27.1](/filings/0001628280-26-055293.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,131,078 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001628280-26-055293.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.